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Aims Changes in circulating brain-derived neurotrophic factor (BDNF) levels were reported in patients with or at risk for car-
diovascular diseases associated with endothelial dysfunction, suggesting a link between BDNF and endothelial function-
ality. However, little is known on cardiovascular BDNF. Our aim was to investigate levels/localization, function, and
relevance of cardiovascular BDNF.
Methods
and results
BDNF levels (western blotting) and localization (immunostaining) were assessed in the heart and aorta from rats with
impaired (spontaneously hypertensive rats [SHR]), normal (Wistar Kyoto rats [WKY]), and improved (SHR and WKY
subjected to physical training) endothelial function. BDNF levels were also measured in cultured endothelial cells
(CECs) subjected to low and high shear stress. The cardiovascular effects of BDNF were investigated in isolated
aortic rings and hearts. The results showed high BDNF levels in the heart and aorta, the expression being prominent
in endothelial cells as compared with other cell types. Exogenous BDNF vasodilated aortic rings but changed neither cor-
onary flow nor cardiac contractility. Hypertension was associated with decreased expression of BDNF in the endothe-
lium, whereas physical training led to endothelial BDNFup-regulationnot only in WKY but also in SHR. Exposureof CECs
to high shear stress stimulated BDNF production and secretion.
Conclusion Cardiovascular BDNF is mainly localized within endothelial cells in which its expression is dependent on endothelial func-
tion. These results open new perspectives on the role of endothelial BDNF in cardiovascular health.
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1. Introduction
Brain-derived neurotrophic factor (BDNF) is a neurotrophin initially
synthesized as a precursor protein (pre-proBDNF) and subsequently
cleaved into proBDNF (35 kDa) that is further processed to generate
mature BDNF (mBDNF, 15 kDa). Mature BDNF is the biologically
active form of BDNF that induces genomic effects consecutive to
TrkB receptors’ activation. Most of what is known on BDNF derives
from studies conducted on the nervous system where the main cellular
source of BDNF is neurons.1– 3 Less well known is that BDNF is also
present in the cardiovascular system. Seminal works showed that
BDNF mRNA expression increased from embryonic to adult stages in
the heart and vessels4 and recognized the involvement of BDNF in the
in utero development of the heart and coronary vasculature.5,6 In con-
trast, the cardiovascular actions of BDNF are still ill-defined in adults.7
Increased BDNF expression was found in human atherosclerotic coron-
ary arteries.8 Decreased plasma BDNF levels were reported in patients
with acute coronary syndrome,9,10 metabolic syndrome,11 or type 2
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diabetes.12 In addition, a positive correlation was observed between
plasma BDNF levels and multiple risk factors for metabolic syndrome
and cardiovascular dysfunction.13 Recently, plasma BDNF was detected
as an independent predictor of 4-year major coronary event in patients
with angina pectoris.14 Overall, clinical data support a contributing role
of BDNF in cardiovascular homeostasis and/or pathogenesis. Moreover,
it is striking that the diseases associated with impaired circulating BDNF
levels share endothelial dysfunction as a common pathophysiological
featureand that circulating BDNF levels inversely correlatewith vascular
cell adhesion molecule-1,15 a biomarker of endothelial dysfunction.16
From these data, BDNF emerges as a potential link between endothelial
function and cardiovascular health.
The present study was designed to investigate levels/localization,
function, and relevance of cardiovascular BDNF in adult rats. For this
purpose, BDNF protein levels and localization were first determined
in the heart and peripheral arteries by using western blotting and immu-
nohistochemical analyses, respectively. Then, we investigated whether
the impairment of endothelial function by hypertension17 or its im-
provement by physical training18 induced changes in BDNF expression.
Lastly, the effect of BDNF on the cardiovascular system was assessed by
using the models of isolated perfused hearts and aortic rings exposed to
exogenous BDNF.
2. Methods
See Supplementary material online.
2.1 Animals
Ten-week-old male Wistar Kyoto rats (WKY, n ¼ 44) and spontaneously
hypertensive rats (SHR, n ¼ 31) were purchased from Charles River
(L’Arbresle, France), housed five per cage and kept under a 12 h–12 h
light–dark cyclewith food and waterad libitum. WKY rats and SHR were ran-
domized in sedentary (WKY, n ¼ 32 and SHR, n ¼ 16) and treadmill-trained
groups (WKY-T, n ¼ 12 and SHR-T, n ¼ 15). All experimental procedures
conformed to the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH publication No. 85-23,
revised 1996) were approved by the local committee for ethic in animal ex-
perimentation. All surgery wasperformed under chloral hydrate anaesthesia
(400 mg/kg, i.p.) and all efforts were made to minimize suffering and stress of
animals. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and
heart rate (HR)weremeasured in conscious ratsbyusing the indirect tail-cuff
method as previously described.19 After anaesthesia, the heart, aorta, brain,
and skeletal soleus muscle were collected and processed according to
further analyses. Physiological parameters and all the organs including the
soleus muscle were collected for 24 h after the last physical training boot
or at corresponding times in sedentary rats.Rats assigned to physical training
were trained 30 min/day in the morning at 18 m/min for 7 consecutive days
using a level motorized rodent treadmill according to a protocol routinely
used in our laboratory.20 The impact of physical training on muscle metabol-
ism was assessed by the measurement of citrate synthase activity21 of the
soleus muscle.
2.2 Cell culture and shear stress treatment
Cultured endothelial cells (CECs, EA-Hy926)22 were exposed to no (static
conditions), low (2 dynes/cm2, LSS), or high shear stress (14 dynes/cm2,
HSS) for 24 h in a Streamer laminar flow chamber. Cells and medium
were stored at 2808C until measurement of BDNF levels.
2.3 Western blots
Pro- (35 kDa) and mBDNF (15 kDa) levels were measured according to our
previous study.20 For cultured cell experiments, both pro- and mBDNF levels
wereassessed incells,whileonlymBDNF levelsweremeasured in themedium
that was previously concentrated 10 times in a Speed-Vac concentrator
system. For rat experiments, pro- and mBDNF levels were measured in the
aorta, heart (left ventricle), and brain (hippocampus). Organs were collected
after transcardiac perfusion with saline and then stored at 2808C.
2.4 Immunostaining and fluorescence
microscopy
Immunofluorescence experiments were performed on aortic and cardiac
sections exposed to anti-BDNF antibody that recognizes both pro- and
mBDNF, to anti-von Willebrand factor (vWF, a marker of endothelial
cells) antibody, and/or to anti-alpha smooth muscle actin (a marker of vascu-
lar smooth muscle cells, VSMCs) antibody.BDNF stainingwasgradedby two
persons blinded to the experimental conditions as follows: grade 0 ¼ no or
mild expression; grade 1 ¼ moderate expression; grade 2 ¼ high expres-
sion; grade 3 ¼ intense expression.
2.5 Aortic vascular reactivity and isolated hearts
Rings collected from the thoracic aorta were suspended in a Krebs solution
maintained at 378C and continuously aerated with 95% O2, 5% CO2 for iso-
metric tension recording in organ chambers as previously described.19 After
a 90-min equilibration period under a resting tension of 2 g, the presence
of functional endothelium was verified by the ability of acetylcholine
(1026 mol/L) to induce more than 80% relaxation in rings preconstricted
with phenylephrine (1026 mol/L). The vascular effect of mBDNF was
assessed in rings previously constricted with phenylephrine (1026 mol/L).
The concentration of mBDNF in the chambers was 1028 mol/L. Besides
heart rate, left ventricular systolic pressure and coronary flow were mea-
sured in Langendorff-perfused hearts exposed for 30 min to the perfusion
buffer with or without mBDNF (15 × 10211 mol/L).
2.6 Statistical analysis
All values were expressed as mean+ standard deviation (SD) except the
grade of cellular BDNF staining intensity that was expressed as median
affected by minimum and maximum values. Differences between groups of
rats and between conditions of cell culture were assessed using the non-
parametric Kruskal–Wallis one-way analysis of variance (ANOVA) followed
by the Mann–Whitney U test to analyse the specific sample pairs for signifi-
cant differences. We compared WKY with SHR to assess the effect of hyper-
tension, sedentary to trained rats to assess the effect of physical training in
WKYorSHR,cells exposedtoshear stress tocells cultured instatic conditions
to assess the effect of shear stress. BDNF levels in the heart and aorta were
compared with those found in the brain of the same rats using Friedman’s
test followedbytheWilcoxon’s test.TheeffectofBDNFvs. vehicleon isolated
aortic rings was compared by the Mann–Whitney U test. Time-response to
BDNF in isolated hearts was analysed using one-way ANOVA for repeated
measures. Statistical significance was set as P, 0.05.
3. Results
3.1 Basic characteristics
The results are summarized in Table 1. As expected, SBP, DBP, and HR
were higher in SHR than in WKY. In these two groups, physical training
did not change any of these parameters, while it significantly increased
the weight and citrate synthase activity of the soleus muscle.
3.2 BDNF is present in high amounts in the
cardiovascular system with a strong
expression in endothelial cells
Experiments were performed in sedentary WKY. Levels of mBDNF
(Figure 1A) and proBDNF (Figure 1B) in the heart and aorta were in the
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same range than those observed in the brain. The spatial pattern of
BDNF staining in cardiac and aortic sections was consistent with an
endothelial localization of the neurotrophin as confirmed by the
co-localization of BDNF with vWF (Figure 1C). No BDNF expression
was observed in other tissue, except a slight expression in the media
of both the aorta and coronary artery. Consistent with the presence
of BDNF in VSMCs, BDNF co-localized with alpha smooth muscle
actin (Figure 2). Regarding the heart, BDNF staining was intense in endo-
thelial cells of the endocardium and absent in other tissue. In the vessels,
BDNF staining was greatly higher in endothelial cells than in VSMCs in
both the coronary artery and the aorta.
3.3 BDNF endothelial staining is dependent
on endothelial function
Evidence of BDNF expression by the healthy endothelium led us to in-
vestigate whether conditions recognized to decrease (essential hyper-
tension) or to improve (physical training) endothelial function can
change endothelial BDNF staining. Results are summarized in Figure 3
(representative figures of BDNF staining in Figure 3A and grade of cellular
BDNF staining in Figure 3B). Hypertension resulted in decreased staining
both in the endocardium and in the vascular endothelium (coronary
artery and aorta), even though the difference did not reach significance
for coronary arteries. Opposite effects were induced by physical training
that resulted in WKY in a significant increase in endothelial BDNF stain-
ing whatever its localization. A trend towards an increase in BDNF stain-
ing was also noticed in VSMCs fromWKY-Twhen compared with WKY.
Notably, the effects of physical training on BDNF staining reported in
WKY were still observed, when physical training was induced in SHR.
As the antibody used to localize BDNF in the aorta and the heart does
not discriminate between pro- and mBDNF, whether changes in endo-
thelial BDNF staining were due to changes in the expression of
proBDNF, mBDNF or both was not known. Therefore, using western
blot analysis, we measured the two forms of BDNF in the whole heart
and aorta. The results are shown in Figure 4. It is noteworthy that the sig-
nificant changes in endothelial BDNF staining induced by hypertension
and physical training (in WKY) in the heart or in the aorta (Figure 3B)
were associated with significant changes in the same direction of pro-
and/or mBDNF levels in the corresponding whole organs. In detail,
decreased endothelial BDNF staining in the aorta and the
endocardium induced by hypertension was associated with reduced
proBDNF levels in the aorta (252%, P, 0.01, Figure 4B), yet without
a decrease in any of the forms of BDNF in the heart. An explanation
for this may be the lack of effect of hypertension on BDNF expression
in the coronary arteries. Regarding the effect of physical training in
WKY, its positive impact on endothelial BDNF staining (endocardium,
coronary artery, and aorta, Figure 3B) was associated with a selective in-
crease by50% (P, 0.05) in mBDNF levels in the aorta (Figure 4A) and
in proBDNF levels in the heart (Figure 4D). In contrast, when induced in
SHR physical training increased mBDNF levels in the heart (Figure 4C,
P, 0.05) and had no effect on the aorta (Figure 4A and B), suggesting
a complex interaction between physical training and hypertension on
BDNF metabolism. The above data indicate that hypertension and phys-
ical training not only target BDNF synthesis in an opposite way but also
that the induced changes likely rely on different mechanisms.
3.4 Exposure of CECs to high shear stress
mimics the effect of physical training on
aortic endothelium
To gain insight into the mechanisms by which physical training induced
endothelial BDNF up-regulation, pro- and mBDNF levels were mea-
sured in CECs subjected to no (static conditions), low (2 dynes/cm2),
or high shear stress (14 dynes/cm2). As shown in Figure 5A, mBDNF
levels in cells exposed to LSS and HSS were 135% (NS) and 457%
(P, 0.01) of values obtained in static conditions, respectively, while
proBDNF levels werenot modified by shear stress. Consistent with a se-
cretion of mBDNF by the cells, mBDNF was detected in the medium in
which the levels were 175 and 320% of values obtained in static condi-
tions after LSS and HSS, respectively (Figure 5B). These data suggest
that the secretion of mBDNF by cells was proportional to shear stress
intensity.
3.5 BDNF induces vasodilation in aorta but
does not change cardiac function
As BDNF originating from endothelial cells may act as an autocrine/para-
crine factor, we examined the effect of exogenous mBDNF on isolated
aortic rings and perfused hearts from sedentary WKY. Exposure of
aortic rings to mBDNF (1028 mol/L) induced a relaxation that gradually
increased from 2 to 10 min (Figure 5C). In contrast, perfusion of hearts
with mBDNF (15 × 10211 mol/L for 30 min) changed neither coronary
flow nor heart rate and contractility (Figure 6).
4. Discussion
Our studyprovides important new findings on BDNF in the adult cardio-
vascular system. First, the heart and aorta contain high BDNF protein
levels, the expression being prominent in endothelial cells when com-
pared with other cell types. Second, unlike the heart, the aorta
appears to be a target organ of BDNF. Third, essential hypertension is
associated with decreased expression of endothelial BDNF, whereas
physical training leads to endothelial BDNF up-regulation not only in
WKY but also in SHR. Fourth, exposure of CECs to high shear stress
mimics the vascular effect of physical training on BDNF.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Basic characteristics
WKY SHR WKY-T SHR-T
Body weight (g) 305+9 255+10** 299+11 252+14
SBP (mmHg) 112+3 180+8** 114+6 182+10
DBP (mmHg) 92+5 150+12** 96+9 150+13
HR (bpm) 296+16 404+30** 291+11 407+15
Soleus muscle
weight (mg)





265+14 284+12 284+19* 332+12††
Body weight, SBP, DBP, HR, weight, and citrate synthase activity of the soleus muscle
were measured in sedentary and trained (T) WKY and SHR. Values are expressed as
means+ SD (n ¼ 14–16 rats per group). Comparisons were done by using the
Kruskal–Wallis test followed by the Mann–Whitney U test.
*P, 0.05 vs. WKY.
**P, 0.001 vs. SHR.
†P, 0.01.
††P, 0.001 vs. SHR.
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The present study is the first to measure pro- and mature BDNF
(mBDNF) levels in the cardiovascular system. Indeed, available data
are scarce and essentially relate to BDNF mRNAs or ELISA-measured
BDNF protein levels in the heart, aorta, pulmonary artery and cultured
brain-derived endothelial cells.23– 26 However, BDNF mRNA is not ob-
ligatorily processed into the mature form of BDNF and ELISA tests do
not distinguish between mature and premature forms of BDNF. Our
results on comparative BDNF levels in the cardiovascular system vs.
the brain are in opposition to the well-accepted idea that the nervous
system contains most of the BDNF that is present in the body. Indeed,
cardiovascular tissue levels of mature and proBDNF were in the same
range as those measured in the hippocampus, which is the brain
region with the highest BDNF levels.20 Moreover, regarding BDNF pro-
duction, our results suggest that the endothelial cell is to the cardiovas-
cular system, what the neuron is to the nervous system. Indeed, the
greatest BDNF expression was found in endothelial cells both in the
heart and vessels, the expression being faint in VSMCs and absent in
cardiomyocytes.
While BDNF appears essential for cardiovascular development,4,5
little is known about the role of BDNF in regulating the adult cardiovas-
cular system.Consistentwith the modulationof vasoreactivity byBDNF,
a relaxant effect of exogenous mBDNF was recently revealed in a model
of pig pulmonary arterial rings.27 In the present study, we reported a dif-
ferential effect of mBDNF on aortic vs. coronary reactivity. Indeed, the
vasorelaxation of aortic rings induced by BDNF contrasted with the
failure of the neurotrophin to increase coronary flow in perfused
hearts. Notably, perfusion of the heart with BDNF was without
impact on contractile function, excluding changes in cardiomyocytes ac-
tivity as a confounding factor. One possible explanation for the differen-
tial effect of BDNF on coronary vs. aortic vasculature might be that
mBDNF concentration in heart perfusion buffer was not high enough
(15 × 10211 vs. 1028 mol/L in the incubation medium of aortic rings).
Another possibility relates to a differential expression of TrkB receptors
among vascular beds as previously shown.25 The present study did not
aim to investigate the signalling pathways involved in BDNF-induced
vasodilation. However, our results showing that the relaxant effect of
Figure1 BDNF expressions in heart and vessels. (A) mBDNF and (B) proBDNF levels (means+ SD, n ¼ 7 sedentary WKY) in the heart and aorta were
compared with those of the brain (hippocampus) by using Friedman’s test followed by Wilcoxon’s test. *P, 0.01 vs. brain. (C) Representative figures of
BDNFstaining in thecardiac ventriclewall, coronary artery, and aorta from WKY. DAPI (blue) andvonWillebrand factor (vWF, green)wereused asnuclear
and endothelial markers, respectively. Red-labelled immunofluorescence represents BDNF. Overlay shows BDNF staining in endothelial cells. Similar
results were observed in all examinations (n ¼ 5–6 rats per organ). CC, cardiac cavity; VL, vascular lumen. Scale bar25–50 mm.
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Figure 2 BDNF expression in vascular smooth muscle cells. Representative figures of the media of the aorta and the coronary artery collected from
sedentary WKY show immunofluorescence staining for DAPI (blue), alpha smooth muscle actin (green), BDNF (red), and the overlay (yellow). Arrow-
heads represent cells staining for BDNF and alpha-actin. Scale bar 10 mm.
Figure3 Endothelial BDNF staining is dependent on endothelial function. (A) Representative figures of BDNF staining (red) in sedentary and trained (T)
WKY or SHR. Similar results were observed in all examinations (n ¼ 4–7 rats per organ). CC, cardiac cavity; VL, vascular lumen. Scale bar 25–50 mm. (B)
Intensity of BDNF staining was graded on a scale from 0 to 3 (0, no or mild expression; 1, moderate expression; 2, high expression; 3, intense expression).
Values are expressed as median affected by minimum and maximum grade value (in brackets). Values were compared by using the Kruskal–Wallis test
followed by the Mann–Whitney U test. *P, 0.05, **P, 0.01 vs. WKY, †P, 0.05, ††P, 0.01 vs. SHR.
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mBDNF occurs within the minute-time frame suggest the involvement
of ‘non genomics’-dependent mechanisms.
It is well documented that physical training has a strong positive link
with cardiovascular health.28 The cardiovascular benefits of physical
training are, at least in part, due to changes in the phenotype of endothe-
lial cells as a result of increased shear stress.29 Although shear stress-
sensing mechanisms are ill-defined, DNA microarray experiments
showed that more than 600 endothelial genes are shear stress respon-
sive.30 The present study reveals that physical training in vivo, like shear
stress in vitro, increasedmBDNFproductionbyendothelial cells, suggest-
ing that mBDNF up-regulation in response to physical training relies on
shear stress-dependent mechanisms. These data apparently contrast
with the sole study on the subject that reported decreased BDNF
levels in the medium of HUVECs exposed to shear stress (24 dynes/
cm2 for 24 h).31 However, in this study, BDNF levels were measured
with ELISA tests. Evidence that proBDNF levels did not increase in re-
sponse to physical training and shear stress is compatible with the
notion that stimulation of the enzymatic cleavage of proBDNF into
mBDNF contributes to physical training-induced increased production
of mBDNF as recently reported for the brain.32,33 To the best of our
knowledge, it is also the first time that physical training is reported to
stimulate BDNF production in organs other than the brain, the spinal
cord, or the skeletal muscle.34– 36 Interestingly, using the same protocol
of physical training, we recently reported the presence of BDNF in the
endothelium of cerebral vessel in trained rats but not in sedentary
rats.20 Accordingly, physical training targets vascular BDNF irrespective
of vessels localization (central vs. peripheral). Moreover, our results may
help the interpretation of clinical studies reporting an elevation in plasma
BDNF levels during and after physical training.37– 40 It was hypothesized
that this increase was due to an enhanced release of BDNF from
the brain41,42 or from platelets.43 Evidence that physical training
up-regulates endothelial BDNF and that endothelial cells secrete
BDNF in response to shear stress (our present results on CECs) sup-
ports endothelium as an alternative source of the BDNF excess found
in plasma during physical training. There is a consensus on neuronal
BDNF as the main chemical translator of the benefits of physical training
on the brain.33 Likewise from our data emerges the hypothesis that
endothelial BDNF might be involved in the benefits of physical training
on the cardiovascular system.
Endothelial dysfunction plays an important role in clinical expression of
significant cardiovascular diseases. It has been consistentlyassociatedwith
cardiovascular risk factors including hypertension and was proposed to
Figure4 Effects of hypertension and physical trainingon cardiovascular BDNF levels. mBDNF (A andC) and proBDNF (B andD) levels were measured in
the heart and aorta from sedentary (SED) and trained (T) WKY or SHR using western blot analysis. Values expressed as means+ SD (n ¼ 7–8 rats) were
compared by using Kruskal–Wallis test followed by the Mann–Whitney U test. *P, 0.05, **P, 0.01 vs. WKY, †P, 0.05 vs. SHR.
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predict a high risk of cardiovascular events.44 The present study reveals a
lower endothelial BDNF expression in the intima of hypertensive SHR
than in their normotensive controls. This new finding completes two pre-
vious studies in SHR that identified an interaction between hypertension
and BDNF metabolism in the brain45 and lungs.46 The mechanisms
involved in hypertension-induced BDNF hypostaining remain to be
furtherexplored. However, an involvementof adefect in endothelial tran-
scriptionof thebdnfgene is suspected fromourresults showingdecreased
proBDNF levels in the aorta. Notably, as physical training did not exert a
hypotensive effect in our conditions, mechanisms independent of blood
pressure lowering are likely involved in hypertension-induced changes
in vascular BDNF metabolism as recently reported for cerebral BDNF
metabolism in stroke prone SHR.47
5. Conclusion
Our results report that BDNF is expressed in a great amount in periph-
eral vessels, where it can act as a local modulator of vasoreactivity and
that endothelial BDNF expression mirrors endothelial function. These
data are compatible with the exciting hypothesis that BDNF can be a
new link between endothelial function and cardiovascular health and
Figure 5 Effect of shear stress on BDNF levels in CECs (A and B) and vasorelaxant effect of BDNF on isolated aortic rings (C). BDNF levels were mea-
sured (A) in CECs and (B) in the culture medium after exposure of cells for 24 h to static conditions, LSS (2 dynes/cm2) or HSS (14 dynes/cm2). Values
(means+ SD, n ¼ 4–5 for each condition) are expressed as percentage of values obtained in static conditions and compared using the Kruskal–Wallis
test followed by the Mann–Whitney U test. *P, 0.01 vs. static conditions. The vascular effect of BDNF was studied on isolated phenylephrine-
preconstricted aortic rings collected from sedentary WKY (C). Rings were exposed to vehicle or recombinant mBDNF (1028 mol/L) and relaxation
was assessed from 2 to 10 min after injection. Values (means+ SD, n ¼ 14 rings) are expressed as the percentage reduction of phenylephrine-induced
tone. *P, 0.05 vs. vehicle after Mann–Whitney U test.
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consequently open new therapeutic avenues in cardiovascular diseases
associated with endothelial dysfunction.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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